Live feed07:00:56·1655dSECFilingvia QuantisnowVYNE Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.VYNE· VYNE Therapeutics Inc.Health CareOriginal source
